tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Sales Growth and Strategic Initiatives Drive Buy Rating for Verrica Pharmaceuticals
PremiumRatingsPromising Sales Growth and Strategic Initiatives Drive Buy Rating for Verrica Pharmaceuticals
3M ago
Verrica Pharmaceuticals Regains Nasdaq Compliance
Premium
Company Announcements
Verrica Pharmaceuticals Regains Nasdaq Compliance
3M ago
Verrica Pharmaceuticals (VRCA) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Verrica Pharmaceuticals (VRCA) Q2 Earnings Cheat Sheet
3M ago
Verrica Pharmaceuticals Amends Collaboration for YCANTH Trial
PremiumCompany AnnouncementsVerrica Pharmaceuticals Amends Collaboration for YCANTH Trial
4M ago
Verrica announces amendment to collab, license agreement with Torri
Premium
The Fly
Verrica announces amendment to collab, license agreement with Torri
4M ago
Verrica Pharmaceuticals Amends Credit Agreement with OrbiMed
Premium
Company Announcements
Verrica Pharmaceuticals Amends Credit Agreement with OrbiMed
5M ago
VRCA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsVRCA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Verrica Pharmaceuticals Announces Resignation of Chief Legal Officer
Premium
Company Announcements
Verrica Pharmaceuticals Announces Resignation of Chief Legal Officer
6M ago
Cautious Outlook on Verrica Pharmaceuticals Amid Restructuring and Market Challenges
Premium
Ratings
Cautious Outlook on Verrica Pharmaceuticals Amid Restructuring and Market Challenges
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100